Reneo Pharmaceuticals, Inc. Common Stock

Go to Reneo Pharmaceuticals, Inc. Common Stock Website

$18.20

(%)
Live
Previous Close

$18.2

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

OnKure, a clinical-stage biopharmaceutical company, has completed its merger with Reneo Pharmaceuticals and raised $65 million in a private placement. The combined company will focus on developing a pipeline of candidates targeting oncogenic mutations in PI3Kα, initially in breast cancer.

Related tickers: RPHM.

Read Full Article

Reneo Pharmaceuticals announced that its stockholders have approved the proposed merger with OnKure, Inc. The combined company will focus on advancing OnKure's pipeline of oncology drug candidates.

Related tickers: RPHM.

Read Full Article
Trending Tickers

Please sign in to view